LucyRx Takes Aim at Menopause Treatment Gaps with Industry-Leading Women’s Health Benefit
Pharmacy-based plan expands hormone coverage, menopause-trained Care Guides and analytics to deliver a clinically proven approach to pharmacy benefits
LucyRx Earns URAC Accreditation
LucyRx continues to raise the bar for prescription care excellence—earning URAC accreditation in Pharmacy Benefit Management and reaffirming its dedication to quality, transparency, and better health outcomes.
LucyRx CCO, Susan Thomas, Wins two Stevie® Awards for Women in Business
Susan Thomas, Chief Commercial Officer at LucyRx, has been awarded a Silver and a Bronze Stevie® Award in the categories of Most Innovative Woman of the Year – Healthcare and Female Executive of the Year, respectively, in the 22nd annual Stevie Awards for Women in Business.
Prescription Benefit Reform is Here: Is Your PBM Ready?
Elisa Muller, Vice President of Legal and Chief Compliance Officer of LucyRx, recently authored an article in BenefitsPRO about pharmacy benefit reform—the legislative efforts to increase transparency, fairness and accountability in the PBM industry.
LucyRx Launches Outcomes Accord to Redefine PBM Accountability
LucyRx just raised the bar for PBM accountability. The Outcomes Accord brings together employers, brokers, and consultants to track what really matters—transparent results, measurable outcomes, and restored trust in prescription care.
LucyRx Completes Acquisition of CerpassRx
LucyRx completes acquisition of CerpassRx, strengthening clinical excellence and expanding access to innovative prescription care. Combination reinforces LucyRx’s proven model of client-first prescription care, expands scale, and enhances clinical depth.
Alex Motola, LucyRx Chief Business Officer, Named Among Becker’s Hospital Review’s 100 Healthcare Leaders Under 40
Alex Motola, LucyRx Chief Business Officer, Named Among Becker’s Hospital Review’s 100 Healthcare Leaders Under 40
What Innovation in PBM Management Really Looks Like
Susan Thomas, Chief Commercial Officer of LucyRx, recently authored an article for Pharmaceutical Executive on what innovation in PBM management really looks like.
LucyRx Defies Industry Trends with NPS of 65
As PBM satisfaction declines industrywide, LucyRx stands out with exceptional service, transparency, and results.
Closing the Health Literacy Gap with David Blair
LucyRx Chief Executive Officer David Blair was recently featured in SIIA’s The Self-Insurer, where he spoke with reporter Bruce Shutan about the intersection of GLP-1 medications and member education.